Image-guided ablation of primary liver and renal tumours

Nature Reviews Clinical Oncology

Volumn 12, Issue 3, 2015, Pages 175-186

  Breen, David J ^a   Lencioni, Riccardo ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; DISEASE SURVEILLANCE; EARLY CANCER; ELECTROPORATION; EVIDENCE BASED MEDICINE; EXTRACORPOREAL FOCUSED ULTRASOUND; HUMAN; IMAGE ANALYSIS; IMAGE GUIDED ABLATION; INTERMETHOD COMPARISON; IRREVERSIBLE ELECTROPORATION; KIDNEY CANCER; KIDNEY CARCINOMA; LIVER CANCER; LIVER CELL CARCINOMA; MICROWAVE THERAPY; MINIMALLY INVASIVE SURGERY; NEPHRECTOMY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR ABLATION; TUMOR MICROENVIRONMENT; ULTRASOUND THERAPY; CATHETER ABLATION; COMPUTER ASSISTED SURGERY; KIDNEY NEOPLASMS; LIVER NEOPLASMS; PROCEDURES;

CATHETER ABLATION; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; SURGERY, COMPUTER-ASSISTED;

EID: 84923817508     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2014.237     Document Type: Review

References (107)

1. International Agency for Research on Cancer. World Health Organization. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012 [online], http://globocan.iarc.fr (2014).
2. Olsen, A. H., Parkin, D. M.&Sasieni, P. Cancer mortality in the United Kingdom: projections to the year 2025. Br. J. Cancer 99, 1549-1554 (2008
3. Davis, G. L., Alter, M. J., El-Serag, H., Poynard, T.&Jennings, L. W. Aging of the hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138, 513-521 (2010
4. Fong, Z. V.&Tanabe, K. K. The clinical management of hepatocellular carcinoma n the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer 120, 2824-2838 (2014
5. Hollingsworth, J. M., Miller, D. C., Daignault, S.&Hollenbeck, B. K. Rising incidence of small renal masses: a need to reassess treatment effect. J. Natl Cancer Inst. 98, 1331-1334 (2006
6. Levi, F. et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int. 101, 949-958 (2008
7. Nguyen, M. M., Gill, I. S.&Ellison, L. M. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J. Urol. 176, 2397-2400 (2006
8. Bruix, J., Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53, 1020-1022 (2011
9. Forner, A., Llovet, J. M.&Bruix, J. Hepatocellular carcinoma. Lancet 379, 1245-1255 (2012
10. Gazelle, G. S., Goldberg, S. N., Solbiati, L.&Livraghi, T. Tumor ablation with radio-frequency energy. Radiology 217, 633-646 (2000
11. Ahmed, M. et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-A 10-year update. Radiology 273, 241-260 (2014).
12. Lubner, M. G., Brace, C. L., Ziemlewicz, T. J., Hinshaw, J. L.&Lee, Jr. F.T. Microwave ablation of hepatic malignancy. Semin. Intervent. Radiol. 30, 56-66 (2013
13. Lubner, M. G. et al. High-powered microwave ablation with a small-gauge, gas-cooled antenna: initial ex vivo and in vivo results. J. Vasc. Interv. Radiol. 23, 405-411 (2012
14. Kurup, A. N.&Callstrom, M. R. Ablation of musculoskeletal metastases: pain palliation, fracture risk reduction, and oligometastatic disease. Tech. Vasc. Interv. Radiol. 16, 253-261 (2013
15. Abbas, A. et al. Image-guided ablation of conn's adenomas in the management of primary hyperaldosteronism. Clin. Radiol. 68, 279-283 (2013
16. Hoffmann, N. E.&Bischof, J. C. The cryobiology of cryosurgical injury. Urology 60 (Suppl. 1), 40-49 (2002
17. Baust, J. G., Gage, A. A., Robilottto, A. T.&Baust, J. M. The pathophysiology of thermoablation: optimizing cryoablation. Curr. Opin. Urol. 19, 127-132 (2009
18. Nakada, S. Y., Lee, F. T. Jr, Warner, T., Chosy, S. G.&Moon, T. D. Laparoscopic cryosurgery of the kidney in the porcine model: an acute histological study. Urology 51 (5A Suppl.), 161-166 (1998
19. Rubinsky, B., Onik, G.&Mikus, P. Irreversible electroporation: a new ablation modality-clinical implications. Technol. Cancer Res. Treat. 6, 37-48 (2007
20. Dubinsky, T. J., Cuevas, C., Dighe, M. K., Kolokythas, O.&Hwang, J. H. High-intensity focused ultrasound: current potential and oncologic applications. AJR Am. J. Roentgenol. 190, 191-199 (2008
21. Lencioni, R. et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer 76, 1737-1746 (1995
22. Huo, T. I. et al. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. Scand. J. Gastroenterol. 38, 770-778 (2003
23. Pacella, C. M. et al. Long-Term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis. J. Clin. Oncol. 27, 2615-2621 (2009
24. Mauri, G. et al. Real-Time US CT/MRI image fusion for guidance of thermal ablation of liver tumours undetectable with US: results in 259 cases. Cardiovasc. Intervent. Radiol. http://dx.doi.org/10.1007/s00270-014-0897-y (2014
25. Goldberg, S. N. et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235, 728-739 (2005
26. Tsoumakidou, G., Buy, X., Garnon, J., Enescu, J.&Gangi, A. Percutaneous thermal ablation: how to protect the surrounding organs. Tech. Vasc. Interv. Radiol. 14, 170-176 (2011
27. DeBenedectis, C. M., Beland, M. D., Dupuy, D. E.&Mayo-Smith, W. W. Utility of iodinated contrast medium in hydrodissection fluid when performing renal tumor ablation. J. Vasc. Interv. Radiol. 21, 745-747 (2010
28. Shock, S. A. et al. Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. Radiology 236, 125-131 (2005
29. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 56, 908-943 (2012
30. Verslype, C., Rosmorduc, O., Rougier P; ESMO Guidelines Working Group. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 23 (Suppl. 7), vii41-vii48 (2012
31. Lencioni, R.&Crocetti, L. Loco-regional treatment of hepatocellular carcinoma. Radiology 262, 43-58 (2012
32. Gervais, D. A. et al. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J. Vasc. Interv. Radiol. 20 (Suppl.), S342-S347 (2009
33. Crocetti, L., de Baere, T.&Lencioni, R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc. Intervent. Radiol. 33, 11-17 (2010
34. Chopra, S., Dodd, G. D. 3rd, Chanin, M. P.&Chintapalli, K. N. Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety. AJR Am. J. Roentgenol. 180, 697-701 (2003
35. Cannon, R., Ellis, S., Hayes, D., Narayanan, G.&Martin, R. C. 2nd. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J. Surg. Oncol. 107, 544-549 (2013
36. Silk, M. T. et al. Percutaneous ablation of peribiliary tumors with irreversible electroporation. J. Vasc. Interv. Radiol. 25, 112-118 (2014
37. Scheffer, H. J. et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J. Vasc. Interv. Radiol. 25, 997-1011 (2014).
38. Lencioni, R. et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 228, 235-240 (2003
39. Lin, S. M., Lin, C. J., Lin, C. C., Hsu, C. W.&Chen, Y. C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma or = 4 cm Gastroenterology 127 1714-1723 2004
40. Shiina, S. et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129, 122-130 (2005
41. Lin, S. M., Lin, C. J., Lin, C. C., Hsu, C. W.&Chen, Y. C. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54, 1151-1156 (2005
42. Brunello, F. et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand. J. Gastroenterol. 43, 727-735 (2008
43. Park, W. et al. Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: focused on the recurrence patterns. Hepatol. Res. 43, 1304-1312 (2013
44. Orlando, A., Leandro, G., Olivo, M., Andriulli, A.&Cottone, M. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-Analysis of randomized controlled trials. Am. J. Gastroenterol. 104, 514-524 (2009
45. Cho, Y. K., Kim, J. K., Kim, M. Y., Rhim, H.&Han, J. K. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49, 453-459 (2009
46. Germani, G. et al. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-Analysis. J. Hepatol. 52, 380-388 (2010
47. Bouza, C., López-Cuadrado, T., Alcázar, R., Saz Parkinson, Z.&Amate, J. M. Meta-Analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol. 9, 31 (2009
48. Lencioni, R. et al. Early-stage hepatocellular carcinoma in cirrhosis: long-Term results of percutaneous image-guided radiofrequency ablation. Radiology 234, 961-967 (2005
49. Tateishi, R. et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103, 1201-1209 (2005
50. Choi, D. et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-Term results and prognostic factors in a large single-institution series. Eur. Radiol. 17, 684-692 (2007
51. N'kontchou, G. et al. Radiofrequency ablation of hepatocellular carcinoma: long-Term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 50, 1475-1483 (2009
52. Lu, D. S. et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 234, 954-960 (2005
53. Rossi, S. et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217, 119-126 (2000
54. Shibata, T et al. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 252, 905-913 (2009
55. Morimoto, M. et al. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 116, 5452-5460 (2010
56. Kim, J. H. et al. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone. Ann. Surg. Oncol. 18, 1624-1629 (2011
57. Peng, Z. W. et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J. Clin. Oncol. 31, 426-432 (2013
58. Lencioni, R. et al. Doxorubicin-eluting bead enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study. J. Hepatol. 49, 217-222 (2008
59. Ahmed, M. et al. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Radiology 235, 469-477 (2005
60. Boutros, C., Somasundar, P., Garrean, S., Saied, A.&Espat, N. J. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surg. Oncol. 19, e22-e32 (2010
61. Groeschl, R. T. et al. Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann. Surg. 259, 1195-1200 (2014
62. Dunne, R. M. et al. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: a comparison of the safety of cryoablation and radiofrequency ablation. Eur. J. Radiol. 83, 632-638 (2014
63. Li, G. Z. et al. Hepatic resection for hepatocellular carcinoma: do contemporary morbidity and mortality rates demand a transition to ablation as first-line treatment? J. Am. Coll. Surg. 218, 827-834 (2014
64. Chen, M. S. et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann. Surg. 243, 321-328 (2006
65. Huang, J. et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann. Surg. 252, 903-912 (2010
66. Feng, K. et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J. Hepatol. 57, 794-802 (2012
67. Wang, Y. et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-Analysis of randomized and nonrandomized controlled trials. PLoS ONE 9, e84484 (2014
68. Kudo, M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 78 (Suppl. 1), 113-124 (2010
69. Lee, C. T. et al. Surgical management of renal tumours 4 cm or less in a contemporary cohort. J. Urol. 163, 730-736 (2000
70. Chawla, S. N. et al. The natural history of observed enhancing renal masses: meta-Analysis and review of the world literature. J. Urol. 175, 425-431 (2006
71. Siu, W., Hafez, K. S., Johnston, W. K. 3rd&Wolf, Jr. J.S. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar. Urol. Oncol. 25, 115-119 (2007
72. Gill, I. S. Focal therapy for kidney and prostate cancer. Curr. Opin. Urol. 19, 125-126 (2009
73. Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E.&Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N. Engl. J. Med. 351, 1296-1305 (2004
74. Remzi, M. et al. Are small renal tumours harmless? Analysis of histopathological features according to tumours 4 cm or less in diameter. J. Urol. 176, 896-899 (2006
75. Miller, D C., Hollingsworth, J. M., Hafez, K. S., Daignault, S.&Hallenbeck, B. K. Partial nephrectomy for small masses: an emerging quality of care concern? J. Urol. 175, 853-858 (2006
76. Van Poppel, H. et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur. Urol. 51, 1606-1615 (2007
77. Fergany, A. F., Hafez, K. S.&Novick, A. C. Long term results of nephron-sparing surgery for localized renal cell carcinoma: 10 year follow-up. J. Urol. 163, 442-445 (2000
78. Porpiglia, F., Volpe, A., Billia, M., Renard, J.&Scarpa, R. M. Assessment of risk factors for complications of laparoscopic partial nephrectomy. Eur. Urol. 53, 590-598 (2008
79. Porpiglia, F., Volpe, A., Billia, M.&Scarpa, R. M. Laparoscopic versus open partial nephrectomy: analysis of current literature. Eur. Urol. 53, 732-743 (2008
80. Froghi, S., Ahmed, K., Khan, M. S., Dasgupta, P.&Challacombe, B. Evaluation of robotic and laparoscopic partial nephrectomy for small renal tumours (T1a). BJU Int. 112, E322-E333 (2013
81. Hinshaw, J. L. et al. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses. AJR Am. J. Roentgenol. 191, 1159-1168 (2008
82. Tuncali, K. et al. Evaluation of patients referred for percutaneous ablation of renal tumours: importance of pre-procedural diagnosis. AJR Am. J. Roentgenol. 183, 575-582 (2004
83. Shannon, B. A., Cohen, R. J., de Bruto, H.&Davies, R. J. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J. Urol. 180, 1257-1261 (2008
84. Kutikar, A.&Uzzo, R. G. The RENAL nephrectomy score: a comprehensive, standardized system for quantitating renal tumour size, location and depth. J. Urol. 182, 844-853 (2009
85. Schmit, G. D. et al. Usefulness of RENAL nephrectomy scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumours. J. Urol. 189, 30-35 (2013
86. Seideman, C. A. et al. Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications. BJU Int. 112, 1121-1124 (2013
87. Ljunberg, B. et al. EAU Guidelines on renal cell carcinoma: the 2010 update. Eur. Urol. 58, 398-406 (2010
88. Breen, D. J.&Railton, N. J. Minimally invasive treatment of small renal tumours: trends in renal cancer diagnosis and management. Cardiovasc. Intervent. Radiol. 33, 896-908 (2010
89. Castle, S M., Salar, N.&Leveillee, R. J. Initial experience using microwave ablation therapy for renal tumour treatment: 18-month follow-up. Urology 77, 792-797 (2011
90. Gervais, D. A., McGovern, E. J., Arellano, R. S., McDougal, W. S.&Mueller, P. R. Radiofrequency ablation of renal cell carcinoma: I. Indications, results, and role in patient management over a 6 year period and ablation of 100 tumours. AJR Am. J. Roentgenol. 185, 64-71 (2005
91. Breen, D. J. et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc. Intervent. Radiol. 30, 936-942 (2007
92. Zagoria, R. J. et al. Oncologic efficacy of CT guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am. J. Roentgenol. 189, 429-436 (2007
93. Pettus, J. A. et al. Percutaneous radiofrequency ablation does not affect glomerular filtration rate. J. Endourol. 24, 1687-1691 (2010
94. Zagoria, R. J. et al. Long-Term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 77, 1393-1397 (2011
95. Tracy, C. R., Raman, J. D., Donnally, C., Trimmer, L. K.&Cadeddu, J. A. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 116, 3135-3142 (2010
96. Ma, Y., Bedir, S., Cadeddu, J. A.&Gahan, J. C. Long-Term outcomes in healthy adults after radiofrequency ablation of T1a renal tumour. BJU Int. 113, 51-55 (2014
97. Atwell, T. D. et al. Percutaneous renal cryoablation: experience treating 115 tumors. J. Urol. 179, 2136-2141 (2008
98. Atwell, T. D. et al. Percutaneous renal cryoablation: local control at mean 26 months follow-up. J. Urol. 184, 1291-1295 (2010
99. Breen, D. J. et al. Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients. BJU Int. 112, 758-765 (2013
100. Schmit, G. D. et al. Percutaneous cryoablation of renal masses or = 3 cm: efficacy and safety in treatment of 108 patients. J. Endourol. 24, 1255-1262 (2010
101. Kunkle, D. A.&Uzzo, R. G. Cryoablation or radiofrequency ablation of the small renal mass: a meta-Analysis. Cancer 113, 2671-2680 (2008
102. Cadeddu, J. A.&Raman, J. D. Renal tumour ablation is a function of patient selection and technique-not the ablation technology. Cancer 113, 2623-2626 (2008
103. Littrup, P. J. et al. CT guided percutaneous cryotherapy of renal masses. J. Vasc. Interv. Radiol. 18, 383-392 (2007
104. Rodriguez, R., Cizman, Z., Hong, K., Koliatsos, A.&Georgiades, C. Prospective analysis of the safety and efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma. Cardiovasc. Intervent. Radiol. 34, 573-578 (2011
105. Schmit, G. D. et al. Percutaneous cryoablation of solitary sporadic renal cell carcinomas. BJU Int. 110, E526-E531 (2012
106. Kim, E. H. et al. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours. BJU Int. 111, 872-879 (2013
107. Georgiades, C. S.&Rodriguez, R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-Arm, 5 year study. Cardiovasc. Intervent. Radiol. 37, 1494-1499 (2014